Dr. Yu Shia Lin, MD

Dr. Lin practices at Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center.

Dr. Lin's NPI, 1407042559, was assigned on September 22, 2007. Dr. Lin holds New York license 243771.

Dr. Lin's primary practice is Maimonides Medical Center, at 4802 Tenth Avenue, Brooklyn, NY 11219 in Kings County. The practice phone is (718) 283-6000.

Dr. Lin's primary practice is Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center. The medical group on file is Maimonides Medical Center. Dmand AI also links Dr. Lin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Lin is licensed in New York.

CMS data shows 333 Medicare services from Dr. Lin across 5 procedure codes in 2024, for 160 Medicare patients. Medicare paid $33,345 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have diabetes, and 75% have high blood pressure. 70% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 62, with 46% women.

In 2024, Dr. Lin wrote 199 Medicare Part D claims for 35 patients. 73% of them were for generic drugs. CMS names the drug for 104 of them, across 7 drugs with 11 or more claims each, at $79,281 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 42 papers to Dr. Lin, published from 2013 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Microscopy, Fluorescence, Antifungal Agents and Breast Neoplasms. Dr. Lin has published most often in Clin Infect Dis. Dr. Lin's most frequent co-authors are Yue Jay Lin, MD, Monica Ghitan, MD and Edward Kurt Chapnick, MD.

CMS Open Payments shows 3 general payments to Dr. Lin from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Theratechnologies Inc. paid the most, $163.